Benjamin F. Edwards & Company, Inc. Ionis Pharmaceuticals Inc Transaction History

Benjamin F. Edwards & Company, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	BUY	$25.61 - $35.1 $1,408 - $1,930	55 Added 85.94%	119 $4,000
Q3 2021 Nov 02, 2021	BUY	$33.54 - $40.55 $268 - $324	8 Added 14.29%	64 $2,000
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $70,219 - $96,059	-2,033 Reduced 97.32%	56 $2,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $2,087 - $2,769	-44 Reduced 2.06%	2,089 $99,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $2,061 - $2,686	44 Added 2.11%	2,133 $126,000
Q3 2019 Nov 05, 2019	BUY	$59.06 - $72.15 $123,376 - $150,721	2,089 New	2,089 $125,000
Q3 2018 Oct 29, 2018	SELL	$42.88 - $53.7 $1,758 - $2,201	-41 Closed	0 $0
Q1 2018 Apr 17, 2018	SELL	$44.08 - $55.05 $3,658 - $4,569	-83 Reduced 66.94%	41 $2,000
Q4 2017 Jan 17, 2018	SELL	$50.3 - $64.39 $1,810 - $2,318	-36 Reduced 22.5%	124 $6,000
Q3 2017 Oct 24, 2017	BUY	$45.56 - $59.57 $7,289 - $9,531	160	160 $8,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.